Webcast
Event Title
Webinar - Clinical Considerations for Studies of Devices Intended to Treat Opioid Use Disorder - Draft Guidance
September 14, 2023
- Date:
- September 14, 2023
- Time:
- 1:00 PM - 2:00 PM ET
Summary
On September 14, 2023, the U.S. Food and Drug Administration (FDA) will host a webinar for industry and other interested stakeholders to discuss the draft guidance: Clinical Considerations for Studies of Devices Intended to Treat Opioid Use Disorder.
During this webinar, the FDA will:
- Discuss the scope and purpose of the draft guidance;
- Discuss the challenges in designing studies of devices intended to treat OUD;
- Discuss the important design features to consider for OUD device studies; and
- Answer questions about the draft guidance.
Add this to my Calendar
Outlook users: Click link, select Open, then click Save & Close
Background
The opioid overdose crisis is a serious and complex challenge facing the United States. The U.S. Food and Drug Administration (FDA), including the Center for Devices and Radiological Health, has taken significant steps to decrease unnecessary exposure to opioids, prevent new cases of opioid use disorder (OUD), and support the treatment of people with OUD.
The Clinical Considerations for Studies of Devices Intended to Treat Opioid Use Disorder draft guidance provides recommendations for the design of pivotal clinical studies for devices intended to treat OUD and used to support marketing submissions. OUD device studies designed using the recommendations set out in this guidance may advance the treatment of OUD by providing scientific evidence that aids FDA in determining whether there is a reasonable assurance that a device intended to treat OUD is safe and effective.
Webinar Details
Registration is not necessary.
Date: September 14, 2023
Time: 1:00 PM - 2:00 PM ET
Please dial in 15 minutes before the start of the call to allow time to connect.
Please click the link below to join the webinar:
https://fda.zoomgov.com/j/1607297163?pwd=NHJ2Q0ozdFpUdzJSYzVBSTVTek81QT09
Passcode: LA@M7i
Please note: Participants who join the webinar using the Zoom webinar link above should use computer audio (listen through their computer speakers and speaking through computer microphone/headset).
The dial-in information provided below is for participants who will be joining the webinar by phone only.
- U.S. Callers Dial: 833-568-8864 (Toll Free)
- For higher quality, dial a number based on your current location:
- +1 669 254 5252 US (San Jose)
- +1 646 964 1167 US (US Spanish Line)
- +1 646 828 7666 US (New York)
- +1 551 285 1373 US
- +1 669 216 1590 US (San Jose)
- +1 415 449 4000 US (US Spanish Line)
- For higher quality, dial a number based on your current location:
- International Caller Dial: Please check the international numbers available
- Webinar ID: 160 729 7163
- Passcode: 772170
Webinar Materials
After the webinar, the presentation, printable slides, and transcript will be available at CDRH Learn under "Specialty Technical Topics," sub-section "Neurological Devices."
Comments
Submit public comments to the draft guidance under docket number FDA-2023-D-0466 at www.regulations.gov by October 26, 2023, to ensure that the FDA considers comments on this draft guidance before it begins work on the final guidance.